Back

Prevalence and influence of cardiovascular kidney metabolic syndrome on outcomes after transcatheter aortic valve implantation

31 August 2026 (10:15 - 11:00)
Organised by: Logo
Congress Presentation Part of: Cardiorenal risk in contemporary practice Renal Failure and Cardiovascular Disease ESC2026 Premium Access ESC Congress 2026 European Society of Cardiology

About the speaker

Photo
Doctor Felix Goetzinger

University Hospital Basel, Basel (Switzerland)

6 More presentations in this session

Presentation thumbnail
Association between vascular access route and exceedance of the maximum allowable contrast dose with medium- to long-term renal function decline in patients undergoing repeated PCI
Doctor P. Steinhoff (Bad Krozingen, DE)
Abstract
Presentation thumbnail
Adverse cardiovascular and renal outcomes in heart failure patients: a prospective cohort from a community heart failure unit (2022–2024)
Doctor M. Barrantes-Castillo (Girona, ES)
Abstract
Presentation thumbnail
In hospital prevalence and mortality associated with individual and combined cardiovascular–kidney–metabolic (CKM) syndrome components: analysis of the national inpatient sample (NIS)
Mr N. Guerithault (US)
Abstract
Presentation thumbnail
Prevalence of echocardiographic abnormalities and their relationship with renal function and cardiac biomarkers in ckd stages 3–4
Doctor M. Covic (Iasi, RO)
Abstract
Presentation thumbnail
Cardiovascular outcomes of ACE inhibitors and angiotensin receptor blockers in kidney transplant recipients: a meta-analysis of randomized trials
Doctor I. Barbosa (Campina Grande, BR)
Abstract

Access the full session

Session thumbnail
Cardiorenal risk in contemporary practice

The Event

Event poster

ESC Congress 2026

31 August 2026 10:15 CET
You may be interested in
thumbnail
Congress Presentation
Cardiovascular-kidney-metabolic syndrome and association with mortality in the UK Biobank prospective cohort study
1 September 2025
thumbnail
Congress Presentation
Impact of obstructive coronary artery disease on clinical and health status in patients undergoing transcatheter aortic valve implantation
1 September 2025
thumbnail
Congress Presentation
Chronic kidney disease impact after mitraclip therapy: five-year outcomes from the GRASP registry
1 July 2021
thumbnail
Congress Presentation
Prevalence and impact of metabolic syndrome in patients with multivessel coronary artery disease and acute coronary syndrome
27 August 2021

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources